BNTC Benitec Biopharma Inc.
Healthcare$11.45+1.96%ClosedMarket Cap: $300.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.03
P/S
0.00
EV/EBITDA
-2.07
DCF Value
$2.67
FCF Yield
-7.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-34.8%
ROA
-26.1%
ROIC
-29.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | NaN% | $-13.6M | $-11.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-13.4M | $-11.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-9.8M | $-9.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-17.2M | $-16.1M | $— | — |
| FY null | $0.00 | NaN% | $-41.8M | $-37.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.3M | $-14.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-10.8M | $-9.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.8M | $-5.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-5.5M | $-4.7M | $— | — |
| FY null | $0.00 | NaN% | $-22.5M | $-21.8M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-4.1M | $-4.3M | $— | — |
| Q2 2024 | $0.00 | -Infinity% | $-6.9M | $-6.8M | $-1.32 | — |